Rep. Spanberger to HHS: Hold Drug Companies Accountable for Breaking the Law, Crack Down on Illegal Price Hikes
January 26, 2022
January 26, 2022
HENRICO, Virginia, Jan. 26 -- Rep. Abigail Spanberger, D-Virginia, issued the following news release:
In response to a rash of reckless decisions by pharmaceutical companies, U.S. Representative Abigail Spanberger is leading a bipartisan effort to protect the 340B Drug Pricing Program and prevent additional prescription drug hikes on Virginia healthcare providers and the communities they serve.
The 340B Drug Pricing Program was enacted by Congress in 1992 with bipartisa . . .
In response to a rash of reckless decisions by pharmaceutical companies, U.S. Representative Abigail Spanberger is leading a bipartisan effort to protect the 340B Drug Pricing Program and prevent additional prescription drug hikes on Virginia healthcare providers and the communities they serve.
The 340B Drug Pricing Program was enacted by Congress in 1992 with bipartisa . . .